To detect and repair damaged DNA, DNA-damage-response proteins need to overcome the barrier of condensed chromatin to gain access to DNA lesions 1 . ATP-dependent chromatin remodelling is one of the fundamental mechanisms used by cells to relax chromatin in DNA repair 2,3 . However, the mechanism mediating their recruitment to DNA lesions remains largely unknown. BRIT1 (also known as MCPH1) is an early DNAdamage-response protein that is mutated in human primary microcephaly 4-8 . Here we report a previously unknown function of BRIT1 as a regulator of the ATP-dependent chromatin remodelling complex SWI-SNF in DNA repair. After damage to DNA, BRIT1 increases its interaction with SWI-SNF through ATM/ ATR-dependent phosphorylation on the BAF170 subunit. This increase in binding affinity provides a means by which SWI-SNF can be specifically recruited to and maintained at DNA lesions. Loss of BRIT1 causes impaired chromatin relaxation as a result of decreased association of SWI-SNF with chromatin. This explains the decreased recruitment of repair proteins to DNA lesions and the reduced efficiency of repair in BRIT1-deficient cells, resulting in impaired cell survival after DNA damage. Our findings therefore identify BRIT1 as a key molecule that links chromatin remodelling with response to DNA damage in the control of DNA repair, and its dysfunction contributes to human disease. Cell culture. U2OS and 293T cells were purchased from the American Type Culture Collection. The U2OS cells were maintained in McCoy's 5A medium supplemented with 10% fetal bovine serum (FBS). 293T cells were grown in DMEM medium with 10% FBS. Lymphoblastoid control cell line and two MCPH cell lines (MCPH 1 (C74G) 7 and MCPH 2 (G321C; A. P. Jackson and E. Griffith, personal communication)] were grown as a suspension culture in RPMI 1640 medium supplemented with 20% FBS.
BRIT1 (BRCT-repeat inhibitor of hTERT expression) was initially identified as a transcriptional repressor of human telomerase reverse transcriptase (hTERT) 4 . Its sequence was later matched to that of a disease gene called microcephalin (MCPH1) 7 . In humans, loss-of-function mutations in BRIT1 cause primary microcephaly (MCPH), which is inherited in an autosomal recessive pattern and characterized by a decrease in brain size to one-third of normal size 7, 8 . BRIT1 contains three BRCT domains and functions as an early DNA-damage-response protein 5, 6 . In addition, dysfunction of BRIT1 impairs the recruitment of DNA damage signalling proteins to DNA lesions 5 . However, it is still unknown how the dysfunction of BRIT1 in DNA damage response leads to MCPH.
To answer this question, we systematically identified the binding partners of BRIT1, among which we found five core subunits of the human SWI-SNF complex: BRG1-BRM, BAF170, BAF155 and SNF5 (ref. 9) ( Fig. 1a ). SWI-SNF is an ATP-dependent chromatin-remodelling complex that uses ATP hydrolysis to alter chromatin structure 10 . The validation of our mass spectrometry result is shown in Fig. 1b and in Supplementary Information, Fig. S1a .
To further characterize the interaction between BRIT1 and SWI-SNF, we first sought to identify the subunit(s) of the SWI-SNF complex that mediated this interaction with BRIT1. Depletion of BAF170 abolished this interaction completely. Depletion of BAF155 also resulted in a loss of interaction between BRG1-BRM and BRIT1, and significantly decreased the interaction between BAF170-SNF5 and BRIT1 (Fig. 1c) . In contrast, the two catalytic subunits, BRG1 and BRM, and also SNF5, were not necessary for interaction between BRIT1 and SWI-SNF ( Supplementary  Information, Fig. S1b-e ). In addition, endogenous SNF5 can pull down other subunits of SWI-SNF in BAF155-deficient or BAF170-deficient cells, excluding the possibility of an unstable SWI-SNF complex resulting from a deficiency in BAF155 or BAF177 ( Supplementary Information,  Fig. S2f ). Our data therefore showed that the core subunits BAF170 and BAF155 mediate interaction between BRIT1 and SWI-SNF. Next we analysed the critical regions that mediated these interactions. An aminoterminal region of BRIT1 was required for its interaction with SWI-SNF ( Fig. 1d ). We also confirmed the direct binding of this region with SWI-SNF with a glutathione S-transferase (GST) pull-down assay, which was not affected by treatment with λ-phosphatase ( Fig. 1e ), indicating that interaction between BRIT1 and SWI-SNF is not dependent on phosphorylation in the absence of DNA damage. When we analysed a series of deletion mutants of BAF155 (ref. 11 ) and BAF170, a conserved SANT domain of BAF155 (residues 595-839) and a region of BAF170 (residues 571-645) were required for their binding to BRIT1 ( Supplementary  Information, Fig. S1g, h) . Taken together, our data clearly establish an interaction between BRIT1 and the SWI-SNF complex, probably mediated through the N-terminal region of BRIT1 and the specific domains of the BAF170 and BAF155 subunits of SWI-SNF.
Because BRIT1 is an early DNA-damage-response protein 5, 6 , we next examined whether the interaction between BRIT1 and SWI-SNF is responsive to DNA damage. The interaction was indeed enhanced 15 min after DNA damage with ionizing radiation (Fig. 2a ). To gain mechanistic insights into this DNA damage-enhanced interaction between BRIT1 and SWI-SNF, we first determined whether the interaction is dependent on ATM (ataxia-telangiectasia mutated) and/or ATR (ATM and Rad3-related), two central kinases in the DNA-damage response network. No apparent change was observed when either ATM or ATR was depleted ( Supplementary Information, Fig. S2a, b ). However, deficiency in both ATM and ATR abolished the damageenhanced interaction without affecting the basal binding affinity (Fig. 2b) . These results suggest that ATM/ATR kinases are required for the DNA-damage-enhanced interaction between BRIT1 and SWI-SNF. ATM/ATR substrates have a common motif, S/TQ. We identified BAF170 (not BAF155) as a potential ATM/ATR substrate, which could be pulled down by phospho-S/TQ (p-S/TQ) antibody in an ATM/ATRdependent manner (Fig. 2c) . We then generated a series of mutations (serine/threonine residues to alanines) on BAF170 S/TQ sites and found that when S969 was mutated, there was a significant decrease in p-S/TQ antibody-binding affinity (Fig. 2d ). The sequences around this site are very similar to those around BRCA1 (S1432), a known ATM/ATR target site 12 ( Supplementary Information, Fig. S2c ), which in fact allowed us to detect p-BAF170 (S969) with the antibody against p-BRCA1 (S1432), while the S969A mutant was not detected ( Supplementary Information,  Fig. S2c ). The phosphorylation of this site was further confirmed by in vitro kinase assays ( Fig. 2e) .
To test the hypothesis that the phosphorylation of S969 by ATM/ATR after DNA damage may increase the binding of BRIT1 to SWI-SNF, we compared the binding affinity of BRIT1 for BAF170 and its S969A mutant, and found that the mutation of BAF170 on S969 blocked its DNA-damage-enhanced binding affinity for BRIT1 but not its basal binding affinity ( Supplementary Information, Fig. S2d ). We then reconstituted BAF170 expression with either the wild type or the S969A mutant construct in BAF170-depleted cells. Although the mutant BAF170 could restore the interaction between BRIT1 and SWI-SNF in the absence of Flag-BRIT1: Flag-N
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BRCT-∆3: DNA damage, it failed to recover their DNA-damage-enhanced interaction. In contrast, wild-type BAF170 readily rescued both ( Supplementary  Information, Fig. S2e ), suggesting that the enhanced interaction between BRIT1 and SWI-SNF in response to DNA damage is mediated through an ATM/ATR-dependent phosphorylation of BAF170.
Recent studies have demonstrated a role for ATP-dependent chromatin remodelling complexes in repairing DNA double-strand breaks (DSBs) 1-3 and in the maintenance of cell survival after DNA damage 13, 14 . We have shown previously that BRIT1 deficiency leads to prolonged H2AX phosphorylation after DNA damage, indicating Input   M1  M2  M3  M4  M5  M6  M7  WT  IgG Heavy chain 
Figure 2
Interaction between BRIT1 and SWI-SNF is responsive to DNA damage. (a) Interaction between BRIT1 and SWI-SNF is enhanced in the presence of DNA damage signalling. Lysates were prepared from cells transfected with empty vector (V) or Flag-BRIT1 (B) at the indicated time points after exposure to ionizing radiation (IR; 10 Gy) and immunoprecipitated (IP). (b) DNA-damage-induced interaction between BRIT1 and SWI-SNF is dependent on ATM/ATR signalling. Cells were harvested 15 min after exposure to ionizing radiation (10 Gy). (c) BAF170 is a substrate candidate for ATM/ATR (top and middle) and its phosphorylation is dependent on the presence of ATM/ATR (bottom). WB, western blot.
(d) The mutation in BAF170 (S969) suppressed the recognition of BAF170 by the p-S/TQ antibody after exposure to ionizing radiation. A series of mutations on BAF170 were generated to replace potential ATM/ATR target sites S/TQ to AQ. Chk2-pulldown by p-S/TQ was used as a positive control to show that the general binding activity of p-S/TQ to other ATM/ATR substrates was not affected in cells transfected with the M7 mutant. (e) BAF170 (S969) is phosphorylated in vitro by ATM/ATR kinase assay. The sequence around BAF170 (S969) was cloned into GST vector (WT) and the phosphomutant (S969A) was made in this vector (Mut. potentially impaired DNA repair 5 . We therefore tested whether the interaction between BRIT1 and SWI-SNF might function in repairing DSB.
First, we used neutral-pH comet assays to demonstrate that BRIT1 deficiency resulted in a significant defect in DSB repair ( Supplementary Information, Fig. S3a, b ). In mammalian cells, two conserved pathways are involved in DSB repair, namely homologous recombination (HR) and non-homologous end joining (NHEJ) 15, 16 . To confirm the role of BRIT1 in DSB repair and to determine which repair pathway it acts in, we analysed BRIT1-deficient cells by using an HR repair analysis system 17 ( Supplementary Information, Fig. S3c, d ) and found that BRIT1 knockdown cells showed a significant decrease The function of BRIT1 in DNA repair is dependent on its interaction with SWI-SNF. BRIT1deficient cells were reconstituted with the indicated plasmids. BRIT1 with N-terminal deletion (BRIT1-ND), which lacks its SWI-SNF interaction domain, was unable to rescue the defect of DNA repair to a similar extent to the BRIT1 BRCT-∆3 mutant, which lost its activity to be recruited to DNA damage lesions. Each value is relative to the percentage of GFP + cells in I-SceI-transfected cells with control siRNA transfection, which was set at 1, and is shown as the mean and s.d. for three independent experiments. Full scans of blots are shown in Supplementary Information (40-60%) in HR-repaired GFP + cells, indicating defective HR repair (Fig. 3a ). The decreased GFP signal was not due to effects on the cell cycle distribution, transfection efficiency or on the cutting efficiency of I-SceI ( Supplementary Information, Fig. S3e-g ). An indirect decrease in HR repair, through decreased expression of BRCA1 by BRIT1 knockdown [18] [19] [20] was also excluded ( Supplementary Information, Fig. S3h , i). During the course of our studies, another study (ref. 21 ) also confirmed this new function of BRIT1 in HR repair.
In parallel, we used the method described in Supplementary Information, Fig. S3j , to analyse NHEJ repair 22 and found that NHEJ repair efficiency was also decreased by 50-60% in BRIT1 knockdown cells ( Fig. 3b ), an effect that was not reversed by ectopic expression of BRCA1, but by the ectopic expression of short interfering RNA (siRNA)-resistant BRIT1 ( Supplementary Information, Fig. S3k ). Taken together, our data reveal a critical function for BRIT1 in both HR and NHEJ repair.
HR and NHEJ are two distinct mechanisms for DSB repair. However, both mechanisms are confronted with DNA wrapped into highly condensed chromatin structure. Therefore, the involvement of BRIT1 in both HR and NHEJ could be explained by their relaxing chromatin structure to allow repair proteins access to DNA lesions. Such access could be provided by BRIT1 facilitating association of the SWI-SNF complex with chromatin and so promoting chromatin relaxation. In the first experiment to examine this possibility, we found that depletion of BRIT1 significantly decreased the amount of chromatin-associated BRG1, BRM, BAF170 and two key DNA repair proteins, Rad51 and Ku70 (refs 15, 16), but their total expression remained constant ( Fig. 3c ; Supplementary Information, Fig. S4a -c).
To examine whether SWI-SNF recruitment was altered specifically at sites of induced DSBs, chromatin immunoprecipitation assays were performed with the I-SceI GFP system described in Supplementary  Information, Fig. S3c . BRM and BRG1 are two catalytic subunits of the SWI-SNF complex. The recruitment of BRM after I-SceI-induced DSB was abolished in BRIT1 knockdown cells ( Fig. 3d ). Both basal and damage-induced DNA localizations of BRG1 were also undetectable in BRIT1 knockdown cells ( Fig. 3d ). In contrast, depletion of individual SWI-SNF subunit affected neither the association of BRIT1 with chromatin nor its recruitment to the DNA damage loci (Supplementary Information, Fig. S4d ), placing SWI-SNF functions downstream of BRIT1.
Because SWI-SNF relaxes chromatin and hence facilitates protein access to chromatin, we reasoned that impaired recruitment of SWI-SNF to chromatin in BRIT1-deficient cells might affect the state of chromatin relaxation and consequently the recruitment of the downstream DNA repair proteins to DNA lesions. To test this hypothesis, we assessed the extent of chromatin condensation by using a micrococcal nuclease (MNase) sensitivity assay, which provides a measure of chromatin compaction 1, 23 . BRIT1 knockdown cells were less sensitive to digestion with MNase in both the absence and presence of DNA damage, indicating that chromatin structure is more compact in BRIT1-deficient cells ( Fig. 4a ; Supplementary Information, Fig. S7h ). Impaired chromatin relaxation and defective HR repair were also observed consistently in SWI-SNF knockdown cells ( Supplementary Information, Fig. S5d-f ).
To show that the function of BRIT1 in chromatin relaxation and DNA repair is dependent on SWI-SNF, we made a small N-terminal deletion (residues 1-48) in BRIT1 (BRIT1-ND), which abolished its interaction with SWI-SNF but preserved its ability to form DNA-damage-induced foci ( Supplementary Information, Fig. S5a, b ). By reconstitution of wildtype BRIT1 or BRIT1-ND in BRIT1-deficient cells, we observed that, in contrast with the wild-type construct, BRIT1-ND was unable to restore the defects in chromatin relaxation and DNA repair in BRIT1 knockdown cells, a phenomenon similar to our observations in cells reconstituted with BRIT1 BRCT1-∆3 ( Fig. 4b ; Supplementary Information, Fig. S5a ). As a consequence, the cells reconstituted with BRIT1-ND still showed increased sensitivity to ionizing radiation (Supplementary Information, Fig. S5c ). Because the BRIT1 BRCT-∆3 mutant (containing only residues 1-752 of BRIT1) could not form DNA-damage-induced foci, it is not surprising that this mutant also failed to restore chromatin relaxation and DNA repair activity.
We also tested whether mutants of BAF155 or BAF170 lacking BRIT1binding activity could exert dominant-negative effects to block a proper DNA damage response such as DNA damage repair ( Supplementary  Information, Fig. S5g-i) . By sequence analysis, we found that BAF155 contained a highly hydrophobic sequence on its BRIT1-interacting domain (SANT), which has been reported to be essential for the function of the SANT domain 24 . This sequence is also conserved in the BRIT1interacting domain of BAF170. We therefore replaced four consecutive leucine residues in BAF155 (residues 629-632) and BAF170 (residues 607-610) with arginine residues. These subtle mutations abolished their binding activity to BRIT1 without affecting their incorporation into the endogenous SWI-SNF complex. Overexpression of these mutants decreased the binding of BRIT1 to other SWI-SNF subunits and thus exerted dominant-negative effects that impaired HR repair in the cells. Taken together, these data further support the notion that dysfunction of SWI-SNF is the underlying mechanism responsible for impaired chromatin relaxation, HR repair and cell survival in BRIT1-deficient cells.
We next tested whether impaired chromatin relaxation would lead to defects in the recruitment of DNA repair proteins to DNA damage sites. The foci formation of Rad51 and phosphorylated replication protein A (p-RPA), key participants in DSB repair 15, 25 , was significantly decreased in BRIT1-depleted cells ( Fig. 4c ; Supplementary Information, Fig. S6a ). The binding of p-RPA34 to chromatin was also impaired. However, treatment with chromatin relaxation agents reversed the effects of BRIT1 depletion on foci formation by RPA, RPA phosphorylation and binding of RPA to chromatin ( Supplementary Information, Fig. S6a-d ). Consistent with this notion, decreased HR repair efficiency in BRIT1 knockdown cells was reversed in the presence of chromatin relaxation agents ( Fig. 4d ), indicating that the impaired recruitment of DNA repair proteins is a direct consequence of impaired access to chromatin in BRIT1-deficient cells.
To confirm the physiological relevance of our findings, we examined lymphoblastoid cell lines (LCLs) from patients with MCPH by using homozygous loss-of-function mutations in BRIT1 ( Supplementary  Information, Fig. S7a ).
Comet assays demonstrated a significantly decreased DSB repair efficiency in BRIT1 LCLs ( Fig. 5a ; Supplementary Information, Fig. S7b ). Consistent with this, BRIT1 LCLs also showed increased sensitivity to the topoisomerase inhibitors camptothecin and etoposide, which generate DSBs during S phase, a cell-cycle phase in which lesions are predominantly repaired by HR 26 . This increased sensitivity was consistent with DSB generation during S phase, because the effects were abrogated when cells were treated with the DNA replication inhibitor aphidicolin (Fig. 5b ). In addition, increased sensitivity to ionizing-radiation-induced DNA damage was observed in BRIT1 LCLs arrested in G1, a cell-cycle phase that exclusively uses NHEJ to repair DSBs ( Supplementary Information, Fig. S7c ). Together, our data suggested that BRIT1 LCLs might have impaired cell survival as a result of generated DSBs being unrepaired because of defects in both HR and NHEJ repair. Furthermore, the formation of repair foci was also impaired in these cells, with significantly reduced recruitment of RPA and Rad51 (Fig. 5c ). These results were further confirmed by our detection of a decreased association of DNA repair proteins to chromatin in patients' cells, whereas total protein levels were unaffected ( Supplementary Information, Fig. S7d-f ).
Binding of SWI-SNF to chromatin was also severely impaired in BRIT1 LCLs (Fig. 5d ). Again, decreased binding of SWI-SNF to chromatin was not due to decreased total cellular protein levels ( Supplementary  Information, Fig. S7e ). In keeping with our BRIT1 siRNA studies, BRIT1 LCLs did not undergo chromatin relaxation after DNA damage, unlike control LCLs. Control LCL chromatin showed increased sensitivity to MNase after neocarzinostatin-induced DNA damage, whereas the chromatin of BRIT1 LCLs remained more resistant to digestion with MNase ( Fig. 5e ; time course shown in Supplementary Information, Fig. S7h ). Induction of chromatin relaxation also restored the damage-induced phosphorylation of RPA in BRIT1 LCLs ( Supplementary Information,  Fig. S7g ). The defects in cell survival and in chromatin relaxation could be rescued by the introduction of wild-type Flag-BRIT1 into BRIT1-deficient LCLs, but not by the introduction of the BRCT-∆1 mutant (containing residues 84-836 of BRIT1), which abrogated its SWI-SNF-binding activity ( Supplementary Information, Fig. S7i-l) . We also found a partial rescuing effect from the BRCT-∆2 mutant (containing a deletion between residues 308-752), which might have been due to the requirement for the carboxy-terminal BRCT domain for other cellular functions 6 . Our findings in BRIT1 LCLs are therefore again consistent with a requirement for BRIT1 in the mediation of chromatin relaxation and the recruitment of DNA repair proteins to DNA lesions after damage to DNA.
Our results suggest a model for BRIT1 function: BRIT1 interacts with SWI-SNF through the core subunits BAF170 and BAF155. These interactions are enhanced in response to DNA damage through an ATM/ATRdependent phosphorylation of BAF170. We suspect that BRIT1 is required for the recruitment and maintenance of SWI-SNF at DNA lesions by promoting chromatin relaxation and in turn facilitating the recruitment of DNA repair proteins to DNA lesions for efficient repair. A loss of BRIT1 would therefore lead to impaired chromatin relaxation and DNA DSB repair, which may contribute to the development of MCPH and cancer.
In addition, besides the recognition of histone modifications by the chromatin remodelling factors 2,3 , our findings reveal a mechanism by which the SWI-SNF complex is recruited to DNA lesions without containing intrinsic specificity for a particular nuclear process 10, 27, 28 . Indeed, multiple mechanisms may be involved in regulating chromatin structure to cope with different stages of damage response and/or response to different types of DNA lesion and/or repair DNA lesions located in different regions of chromatin (euchromatin or heterochromatin) 1, 23, 29 . In addition, our studies reveal that post-translational modifications such as phosphorylation may serve as critical mechanisms in regulating the functions of SWI-SNF. It will therefore be of interest to determine the additional roles of phosphorylation on other SWI-SNF subunits in the DNA damage response 12 and dysfunction in the pathogenesis of human diseases 30, 31 .
MeTHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/ Note: Supplementary Information is available on the Nature Cell Biology website.
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We thank S. Rosenberg, X. Shen and F. Meric-Bernstam for critical reading of the manuscript; S. Deming for proofreading it; M. Jasin for reagents; E. Griffith for identifying the mutation in the MCPH no. Published online at http://www.nature.com/naturecellbiology reprints and permissions information is available online at http://npg.nature.com/ reprintsandpermissions/ Purification of GST fusion proteins and GST pulldown assay. Purification and GST pulldown methods were adapted from a previous publication 32 . BL21 bacteria containing indicated plasmids were allowed to grow for 6 h after the addition of isopropyl β-d-thiogalactoside. Cell pellets were resuspended in lysis buffer and sonicated. The supernatant was incubated overnight with glutathione-agarose beads at 4 °C. After washing, GST fusion proteins were eluted with glutathione. Then cell lysates (1 mg) were incubated with 2-5 µg of GST fusion protein and 40 µl of gluthatione-agarose beads in a total of 1 ml of RIPA buffer at 4 °C on a rotator for 2-4 h. After the beads had been washed three times with RIPA buffer, the protein was eluted for SDS-PAGE gel analysis.
In vitro ATM and ATR kinase assay. Immunoprecipitations of ATM and ATR and the in vitro kinase assay were performed as described previously 33 . In brief, 293T cells were transfected with 8 µg of Flag-tagged ATM, ATR, ATM-KD and ATR-KD plasmids. Cell extracts were prepared in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Tween 20, 0.3% Nonidet P40, 1 mM sodium fluoride, 1 mM Na 3 VO 4 , 1 mM PMSF, 50 mM glycerophosphate, 1 mM dithiothreitol, 1 mM EGTA, 10% glycerol and 1 × protease inhibitor mixture from Roche Molecular Biochemicals). Cleared supernatants were immunoprecipitated with anti-Flag M2 antibody (Sigma). After being washed five times with lysis buffer and kinase buffer (20 mM HEPES pH 7.5, 50 mM NaCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 10 mM MnCl 2 ), the immunoprecipitate was resuspended in 50 µl of kinase buffer containing 10 µCi of [γ-32 P]ATP, 10 µM ATP, 1 mM sodium fluoride, 1 mM Na 3 VO 4 , 20 mM glycerophosphate and 1 µg of GST fusion substrate. The kinase reaction was performed at 30 °C for 20 min and stopped by the addition of SDS sample buffer. Proteins were separated by SDS-PAGE and transferred to poly(vinylidene difluoride) membrane. Radiolabelled proteins were revealed by autoradiography.
Antibodies, immunoprecipitation, chromatin fractionation and western blot analysis. BRIT1, BRCA1, RPA34 and p-RPA34 antibodies were described previously 5, 22 . Rabbit anti-SWI/SNF subunit antibodies (BRG1, BRM, BAF170, BAF155 and SNF5), MCM2 and p-MCM2 (Ser40/Ser41) were purchased from Bethyl Laboratory. Rabbit anti-Rad51 (Ab-1) antibody was purchased from Calbiochem. Mouse anti-Ku70 antibody was purchased from Novus. Control rabbit immunoglobulin G (IgG) and anti-ATR antibody were purchased from Santa Cruz. Anti-Mcy tag antibody, Chk1, p-Chk1 (Ser 345), Chk2, p-Chk2 (Ser 68), p-S/TQ antibodies and anti-ATM antibody were ordered from Cell Signaling. Immunoprecipitation with anti-Flag affinity beads was performed as described above. For reciprocal immunoprecipitation, whole-cell extracts were prepared in RIPA buffer as indicated above and pre-cleaned with Protein A/G plus-agarose beads (Santa Cruz). Cell extracts were then subjected to incubation for 2 h with antibodies against BRG1 or BRGM (2 µg) followed by incubation overnight with Protein A/G-agarose beads at 4 °C. The immunocomplex was eluted in loading buffer by being boiled for 5 min at 95 °C. The preparation of chromatin fractions and western blot analyses, including the conditions for RPA analysis, were performed as described previously 5, 22 . For the chromatin fractions to analyse SWI/ SNF and DNA repair proteins, cells were exposed to ionizing radiation (10 Gy), then harvested 2 and 5 h later, respectively. Densitometry analysis was performed with National Institutes of Health IMAGE software.
Chromatin immunoprecipitation (ChIP) assay. DSBs were induced in cells transfected with control siRNA or BRIT1 siRNA 1 by I-SceI expression. At indicated time points, cells were crosslinked with formaldehyde and ChIPs were performed with an EZ ChIP kit (Upstate) in accordance with the manufacturer's instructions. Cellular lysates were subjected to five sets of sonication on wet ice with a 60 Sonic Dismembrator (Fisher Scientific). Each set consisted of 8 s of sonication separated by 1-min intervals on ice. BRG1 and BRM (10 µl) antibodies were used for immunoprecipitation. The ChIP primers used to analyse proteins binding at the site of DSBs were 5´-TACGGCAAGCTGACCCTGAA-3´ (sense) and 5´-GCCCATATATGGAGTTCCGC-3´ (antisense).
The primers used as a negative control on chromosome 12 were 5´-ATGGTTG-CC AC TGG GGATCT-3´ (sense) and 5´-TGCCAA AG CCTAGGGGAAGA-3´ (antisense).
Methods for the following assays are available in Supplementary Information: DNA repair assays (comet assay, HR repair analysis, NHEJ repair analysis), cell cycle analysis, MNase sensitivity assay, colony-forming assay, cell viability assay, and immunofluorescent staining for foci formation.
Statistical analysis. All statistical analysis was performed with a one-tailed Student's t-test.
BRIT1-SWI/SNF interaction. Flag-BRIT1 and a series of deletion mutants of BAF155 tagged with c-Myc were expressed in cells to assess their ability of interaction. Cell lysates were immunoprecipitated with Flag affinity beads and blotted with the indicated antibodies. cells were transfected with wild-type or S969A mutated (M7) BAF170. 48 hrs after transfection, cells were exposed to IR (10 Gy). 1 hr later, cell lysates were harvested and incubated with anti-p-SQ/TQ or anti-p-BRCA1 (S1423) antibody. Similar condition was also used for Fig. 2c and Fig. 2d. (d) The binding between BAF170 mutant M7 (S969A) and BRIT1 did not increase after IR. 293T cells were transfected with indicated plasmids. Immunoprecipitation was performed by anti-Flag M2 antibody and detected by anti-Myc-tag antibody on Western blot. (e) In BAF170 depleted cells, reconstitution of BAF170 mutant M7 (S969A) was unable to rescue IR-enhanced BRIT1-SWI/SNF interaction.
(Left) The expression levels of endogenous and ectopic BAF-170 in the cell lysates. (Right) Endogenous SWI/SNF subunits associated with BRIT1 were detected by the indicated antibodies in immunoprecipitation assay. Cells were transfected with indicated plasmids and 5 hrs later, BAF170 was depleted by siRNA transfection. 48 hrs after the transfection, cells were harvested and immunoprecipiation was performed as above. Supplementary Fig. 2 The function of BRIT1 in chromatin relaxation is dependent on its interaction with SWI/SNF. BRIT1 with N-terminal deletion (BRIT1-ND), which lacks its SWI/SNF interaction domain, was unable to rescue the defect of chromatin relaxation. (b) Foci formation of indicated Flag-tagged BRIT1 proteins detected by immunostaining with anti-Flag M2 antibody 1 hrs after IR (10 Gy). Scale bar is 10 µM. (c) BRIT1-ND-reconstituted cells were sensitive to IR. Indicated plasmids were transfected into U2OS cells and then treated with control or BRIT1 siRNAs. 2 days later, cells were plated at low density and exposed to IR. Colonies were counted 2 weeks later. The graph represents the mean ± SD of three independent experiments (d) Western blots for BRM and BAF155 knockdown efficiency. (e) Impaired chromatin relaxation analyzed by MNase sensitivity assay in BRM or BAF155 knockdown cells. (f) Impaired HR repair in BRM or BAF155 knockdown cells analyzed 48 hours after I-SceI transfection. Each value is relative to the percentage of GFP+ cells in I-SceI-transfected cells with control siRNA expression, which was set to 1 and represents the mean±SD of three independent experiments. Student t-test. (g) (Top) sequences indicating conserved hydrophobic sequences on BAF155 and BAF170. Mutations were made at corresponding sites to replace leucines to arginines. (Bottom) L4R mutants of BAF155 and BAF170 can be incorporated into endogenous SWI/SNF complex. 293T cells were transfected with indicated plasmids. 48 hrs later, immunoprecipitation was performed using anti-SNF5 antibody. (h) L4R mutants lack their binding activities to BRIT1 and can exert dominant-negative effects toward BRIT1-SWI/ SNF interaction. Cells were co-transfected with Flag-BRIT1 and indicated plasmids. 48 hrs later, immunoprecipitation was performed using anti-Flag M2 beads. (i) Impaired HR repair in cells transfected with L4R mutants of BAF155 or BAF170 (Left) Western blots that showed ectopic expression of indicated plasmids. (Right) GFP analyses were performed 48 hours after I-SceI transfection. Each value is relative to the percentage of GFP+ cells in I-SceI-transfected cells with empty vector transfected, which was set to 1 and represents the mean±SD of three independent experiments. 
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Micrococcal nuclease (MNase) sensitivity assay
To induce DNA damage, U2OS cells were treated with 4 Gy IR. MCPH cell lines were treated with the DSB inducing agent neocarzinostatin (400 ng/mL) (Sigma) for 2 hr. Cells mM CaCl 2 and 0.5 mM DTT). Aliquots (50 µl) were prepared at 1 min, 2 min, and 5 min.
Genomic DNA was purified and separated by electrophoresis in 1.2% agarose gel. Band intensity was determined using NIH IMAGE software. The average nucleosome size was calculated as described previously 4 . Briefly, intensity of each lane and intensity of individual band in each lane were obtained. Oligonucleosome average size was calculated as ∑ N1-Ni (NiP Ni ), where Ni is the oligonucleosome size (expressed as number of nucleosomes) and P Ni is the fraction of that oligonucleosome out of the total scan calculated as the ratio of specific band intensity to the intensity of the whole lane.
Statistical significance of the difference in average oligonucleosome size between the control group and BRIT1 deficient groups were analyzed by Student's t-test.
Colony-forming assay
Transfection and colony-forming assay were performed as previously described 5 . Briefly, U2OS cells were transfected with indicated plasmids, and 5 h later were transfected with BRIT1 siRNA. Cells were exposed to IR two days after transfection, seeded at low density and left for 2 weeks to allow colonies to form. Colonies were stained with 2% methylene blue/50% ethanol and counted. Colonies containing 50 or more cells were counted.
Cell viability assay
The sensitivity of MCPH cells to DSB-inducing agents was analyzed using CellTiter 96 Aq ueous One Solution Cell Proliferation Assay (MTS assay, Promega). Briefly, 1x10 4 cells/well were seeded in a 96-well plate in a total volume of 100 µl in triplicate in each experiment. The next day, cells were treated with the DSB-inducing agent etoposide (Sigma) or camptothecin (Sigma) at indicated concentrations. To inhibit DNA replication, cells were pre-incubated with aphidicolin (Sigma) for 90 min before treatment with DSB-inducing agents. Seventy-two hours later, the number of surviving cells was assayed using MTS solution. G1 arrest in patient cells was induced as described previously 6 . Cell cycle arrest was confirmed by flow cytometry. Arrested cells and nonsynchronized cells were exposed to IR (10 Gy). Cell viability assay was performed 72 h
